Vertex: New non-opioid painkiller Journavx approved by US FDA
Source: BBC
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA).The drug suzetrigine, known by its brand name Journavx, works by targeting pain signals before they reach the brain.Its manufacturer Vertex Pharmaceuticals said this enables it to provide effective relief for moderate to severe pain without "the addictive potential of…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at BBC